Neurogene Inc. (NGNE) at a glance

Neurogene Inc. (NGNE) is a Healthcare company. It trades at $29.19. It does not pay a dividend. Vestovix scores it 51/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Income (40/100).

Price
$29.19
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$14.65 to $37.27
Vestovix Score51/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
60